Skip to main content

Table 3 Cox regression analysis

From: A real world example of coverage with evidence development in Australia - ipilimumab for the treatment of metastatic melanoma

Parameter tested

p-value Hazard ratio [95% CI] (if relevant)

Age

p = 0.1644

Body weight

p = 0.4476

Gender

p = 0.1750

 Female vs Male

1.163 [0.94; 1.45]

ECOG performance status

p < 0.0001

 1: Restricted vs 0: Active

1.76 [1.42; 2.18]

 2: Self-care capable vs 0: Active

3.00 [2.13; 4.22]

 3: Limited self-care capable vs 0: Active

6.91 [3.64; 13.11]

 4: Disabled vs 0: Active

629.65 [56.44; 7024.33]

M Status

p = 0.0005

 M1a vs M1c

0.54 [0.43; 0.81]

 M1b vs M1c

0.66 [0.36; 0.82]

Previous brain metastases

p = 0.2622

 No vs Yes

0.88 [0.71; 1.10]

Treatment naive

p = 0.0114

 No vs Yes

1.29 [1.06; 1.57]

Hospital

p = 0.7601

 Private vs Public

0.965 [0.77; 1.21]

Community

p = 0.5048

 Urban vs Rural

1.07 [0.88; 1.31]